Crestline Management, LP Organogenesis Holdings Inc. Transaction History

Crestline Management, LP

  • $2.93 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$6.47 - $9.57 $1.01 Million - $1.5 Million
-156,279 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$9.02 - $13.5 $214,703 - $321,340
-23,803 Reduced 13.22%
156,279 $1.44 Million
Q3 2021

Nov 12, 2021
BUY
$13.71 - $17.18 $2.47 Million - $3.09 Million
180,082 New
180,082 $2.56 Million

Others Institutions Holding ORGO

# of Institutions
124
Shares Held
62M
Call Options Held
4.3K
Put Options Held
3.9K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $639M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Crestline Management, LP Portfolio

Follow Crestline Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Crestline Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email